carbamazepine has been researched along with Reperfusion Injury in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JS | 1 |
| Wang, JH | 1 |
| Biel, TG | 1 |
| Kim, DS | 1 |
| Flores-Toro, JA | 1 |
| Vijayvargiya, R | 1 |
| Zendejas, I | 1 |
| Behrns, KE | 1 |
1 other study available for carbamazepine and Reperfusion Injury
| Article | Year |
|---|---|
Carbamazepine suppresses calpain-mediated autophagy impairment after ischemia/reperfusion in mouse livers.
Topics: Animals; Anticonvulsants; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 7; Bec | 2013 |